Development: Cancer Outreach Core

发展：癌症外展核心

• 批准号: 8340678
• 负责人: Maureen Sanderson
• 金额: $ 5.14万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-26 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8340678
• 关键词: African American; Awareness; Biometry; Clinical Trials; Communities; Community Health Centers; Development; Diagnosis; Discipline of obstetrics; Doctor of Philosophy; Epidemiologist; Epidemiology; Funding; Grant; Gynecology; Hispanics; Human Papilloma Virus Vaccine; Human Papillomavirus; Human Resources; Institutes; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Malignant neoplasm of prostate; Minority; National Center on Minority Health and Health Disparities; Pilot Projects; Public Health; Public Health Schools; Recruitment Activity; Research; Research Personnel; Research Project Grants; Testing; Texas; The Sun; The Vanderbilt-Ingram Cancer Center at the Vanderbilt University; Training; Universities; Washington; Woman; anticancer research; breast density; cancer health disparity; experience; malignant breast neoplasm; operation; outreach; professor; social

The experience of key technical personnel who will be responsible for the day-to-day operation Maureen Sanderson, Ph.D., will replace Dr. Paul Juarez as MMC Co-leader in the next cycle, given her extensive involvement with the COC and affiliated research projects. She has training in epidemiology and biostatistics (Ph.D., Univ. of Washington, 1996) and is Professor of Obstetrics and Gynecology at MMC. Dr. Sanderson has 14 years experience as Pl for efiologic and intervenfion studies of prostate, breast and cervical cancer that focus on African Americans and Hispanics. She has extensive experience in collaborating with public health departments, community health centers, and other community partners on cancer research. Dr. Sanderson was recruited to MMC in 2008 to serve as the Senior Epidemiologist for the Partnership. She is also the Scienfific Director for the NCI-funded Meharry-CHC CNP (recenfiy renewed for a second cycle), and PI of the full research project (with Dr. Hull as Co-PI). Drs. Sanderson, Hull, and Khabele are currentiy conducfing a pilot study under the Partnership to test a culturally-tailored social markefing intervenfion for increasing HPV vaccine ufilizafion among Hispanic giris. Dr. Sanderson is co-investigator on an efiologic study of breast density funded by the DOD and on the NCI-funded P20, "MMC-VICC: Partners in Cancer Sun/ivorship." Prior to joining MMC, she was Director of the Cancer and Training Cores of an NCMHD EXPORT planning grant at the University of Texas-Houston School of Public Health at Brownsville, which assessed the need for educational messages for women diagnosed with HPV. In 2005 Dr. Sanderson attended the same CBPR training institute as Dr. Hull mentioned above.

关键技术人员的经验，他们将负责日常运营 莫琳·桑德森（Maureen Sanderson）博士将在下一个周期中取代保罗·华雷斯（Paul Juarez）博士为MMC共同领导者 广泛参与COC和关联研究项目。她接受了流行病学和 生物统计学（华盛顿大学博士，1996年），是MMC的妇产科教授。博士 桑德森（Sanderson 专注于非裔美国人和西班牙裔的癌症。她与 公共卫生部门，社区卫生中心和其他有关癌症研究的社区合作伙伴。博士 桑德森（Sanderson）于2008年被招募到MMC担任该合作伙伴关系的高级流行病学家。她是 也是NCI资助的Meharry-CHC CNP（重新续签第二个周期）的理事会主任，并且 完整的研究项目的PI（与赫尔博士为Co-Pi）。博士。桑德森，赫尔和哈比尔是当前的 在合作伙伴关系下辅导一项试点研究，以测试一项经过文化的社会马克菲干预 在西班牙裔giris中增加了HPV疫苗ufilizafion。 Sanderson博士是一项电子研究的共同评估者 由国防部和NCI资助的P20资助的乳房密度，“ MMC-VICC：癌症的伴侣 太阳/ivorship。”在加入MMC之前，她曾是NCMHD的癌症和培训核心 布朗斯维尔的德克萨斯 - 休斯顿大学公共卫生学院的出口计划赠款， 评估了对被诊断为HPV的妇女的教育信息。 2005年桑德森博士 与上述赫尔博士一起参加了同一CBPR培训学院。